KCNA3 and type 1 diabetes mellitus: Selective targeting of TEM cells in multiple sclerosis or diabetes mellitus type 1, where only pathogenic T cell clones have been noted to express high Kv1.3, provides the opportunity to delete/inhibit disease-causing clones without compromising the overall immune system.